Patent · US Expired

Caspases and apoptosis

US6514992B1 · kind B1 · utility

0Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2000
Grant dateFeb 4, 2003
Priority date
Expiry dateDec 14, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention is to novel compounds of Formula (I), their pharmaceutical compositions, and to the novel inhibition of Caspases for use in the treatment of apoptosis, and disease states caused by excessive or inappropriate cell death.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.